Lv2
150 积分 2026-07-08 加入
Abstract 6180: First-in-human (FIH) phase I studies of SCB-313, a novel TNF-related apoptosis-inducing ligand TRAIL-Trimer™ fusion protein, for treatment of patients (pts) with malignant ascites (MA)
12天前
已关闭
First-in-human (FIH) phase I studies of SCB-313, a novel TNF-related apoptosis-inducing ligand TRAIL-Trimer™ fusion protein, for treatment of patients (pts) with malignant ascites (MA)
12天前
已关闭
Minimal seasonal variation in disease parameters of axial spondyloarthritis: a register-based study
1个月前
已完结
Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review
1个月前
已完结
POS1063 ULVIPRUBART PHARMACOKINETICS, PHARMACODYNAMICS (PK/PD), AND SAFETY: PHASE 1 STUDY RESULTS IN PATIENTS WITH INCLUSION BODY MYOSITIS (IBM)
1个月前
已完结
皖公网安备34019202002308
